Source content
FAA Guide for Aviation Medical Examiners · Version 10/28/2026 · page 910
Guide Official Revision Description Reason for Update
Version Date Number Of Change
2014 01/16/2014 2. Medical Policy In Pharmaceuticals
(Therapeutic Medications),
add new “Do Not Issue-Do
Not Fly” section.
2014 01/01/2014 1. Administrative Revise cover page to reflect
the current calendar year.
2013 12/23/2013 1. Administrative In Pharmaceutical
(Therapeutic Medications),
Sleep Aids, add link to FDA
study.
2013 12/12/2013 1. Medical Policy In Pharmaceutical
(Therapeutic Medications),
Acne Medications, revise
policy to include language on
use of topical acne
medications, such as Retin
A, and oral antibiotics, such
as tretracycline.
2013 12/06/2013 1. Administrative In AASI, change title of Deep
Venous
Thrombosis/Pulmonary
Embolism - Warfarin
(Coumadin) Therapy to
“Deep Venous Thrombosis
(DVT), Pulmonary Embolism
(PE), and/ or
Hypercoagulopathies”. Title
of block on the Certificate
Issuance sheet also
changed.
2013 11/06/2013 1. Medical Policy In Item 46. Neurologic,
revise the Cerebrovascular
Disease dispositions table to
expand on criteria for
Transient Ischemic Attack,
Completed Stroke (ischemic
or hemorrhagic), and
Subdural, Epidural, or
Subarachnoid Hemorrhage.
2013 09/27/2013 1. Medical Policy In General Information,
Equipment Requirements –
Color Vision Test Apparatus,
remove Titmus II Vision
Tester (Model Nos. TII and
TIIS) from the list of
approved testers.
Shown as extracted from the FAA PDF, without paraphrasing. Tables and forms may lose their layout. Underlined references open the Guide location they name.
